Breaking News Instant updates and real-time market news.

RDS.A

Royal Dutch Shell

$51.50

0.95 (1.88%)

, RDS.B

Royal Dutch Shell

$54.82

0.8 (1.48%)

10:22
10/14/16
10/14
10:22
10/14/16
10:22

On The Fly: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A, RDS.B) downgraded to Sell from Hold at Canaccord with the firm citing the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. 2. bluebird bio (BLUE) downgraded to Sell from Hold at Cantor with analyst Elemer Piros saying he sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. 3. Fluor (FLR) downgraded to Neutral from Accumulate at Seaport Global with analyst Ryan Cassil citing persistently weaker global macroeconomic trends and expectations for a continuation of weaker project activity in 2017. 4. Boston Beer (SAM) downgraded to Hold from Buy at Berenberg. 5. Estee Lauder (EL) downgraded to Neutral from Overweight at Piper Jaffray after the firm's semi-annual proprietary "Taking Stock With Teens" survey. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RDS.A

Royal Dutch Shell

$51.50

0.95 (1.88%)

RDS.B

Royal Dutch Shell

$54.82

0.8 (1.48%)

BLUE

bluebird bio

$65.24

-0.31 (-0.47%)

FLR

Fluor

$49.97

-0.35 (-0.70%)

SAM

Boston Beer

$154.88

-8.3 (-5.09%)

EL

Estee Lauder

$87.80

-0.35 (-0.40%)

  • 03

    Nov

  • 06

    Nov

  • 29

    Nov

RDS.A Royal Dutch Shell
$51.50

0.95 (1.88%)

08/10/16
08/10/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Adobe (ADBE) initiated with an Overweight at Stephens. 2. Royal Dutch Shell (RDS.A) coverage resumed with a Market Perform at Raymond James. 3. Sientra (SIEN) resumed with a Market Perform at William Blair. 4. Synchronoss (SNCR) initiated with an Overweight at Stephens. 5. AdvancePierre Foods (APFH) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/16
BERN
09/08/16
DOWNGRADE
BERN
Market Perform
Total downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Oswald Clint, downgraded Total (TOT) based on his new analysis which shows that its upstream ROIC ranks fifth among the European integrated oil names he covers. The analyst says that Shell (RDS.A), BP (BP), and Eni (E) rank first, second, and third, respectively.He set a $56.61 price target on Total.
10/14/16
ADAM
10/14/16
DOWNGRADE
ADAM
Sell
Royal Dutch Shell downgraded to Sell from Hold At Canaccord
Canaccord downgraded Royal Dutch Shell to Sell from Hold based on the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. Canaccord said the company would require at least a five-fold improvement from the 20-year average and a ten-fold improvement from the 10 year average to make its medium-term goals.
09/08/16
BERN
09/08/16
DOWNGRADE
BERN
Underperform
Repsol downgraded to Underperform from Market Perform at Bernstein
Bernstein analyst Oswald Clint downgraded Repsol (REPYY) based on his new analysis which shows that its upstream ROIC ranks sixth among the European integrated oil names he covers. The analyst says that Shell (RDS.A), BP (BP), and Eni (E) rank first, second, and third, respectively. He set an EUR11.30 price target on Repsol, down from EUR13 previously.
RDS.B Royal Dutch Shell
$54.82

0.8 (1.48%)

03/11/16
03/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Finisar (FNSR) upgraded to Buy at Craig-Hallum and B. Riley, following the company's Q3 results. Craig-Hallum analyst Richard Shannon was encouraged by guidance in a seasonally difficult part of Finisar's year and believes the company has reached the inflection point he has been waiting for. 2. Diamond Offshore (DO) upgraded to Neutral at Goldman and Piper Jaffray, with analysts citing an improved relative valuation, the company's balance sheet, and liquidity. 3. Cenovus Energy (CVE) upgraded to Conviction Buy at Goldman by analyst Neil Mehta, who cited the company's strong 2017 free cash flows, improving commodity prices, high quality assets, and relative underperformance. 4. Weatherford (WFT) upgraded to Buy at Goldman with analyst Waqar Syed saying Weatherford will be a beneficiary of an expected recovery in US land drilling activity in 2017. He added that investors will benefit from cost cutting and restructuring measures taken over the past two years. 5. Royal Dutch Shell (RDS.A) upgraded to Conviction Buy at Goldman due to expectations for a growing dividend yield driven by cost cutting, capital discipline, the realization of synergies, and rising oil prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/16
RBCM
08/01/16
DOWNGRADE
RBCM
Sector Perform
Royal Dutch Shell downgraded on valuation, debt at RBC Capital
As noted earlier, RBC Capital downgraded Royal Dutch Shell to Sector Perform from Outperform. As reasons for the downgrade, analyst Biraj Borkhataria cited valuation and the company's debt burden.
BLUE bluebird bio
$65.24

-0.31 (-0.47%)

10/14/16
CANT
10/14/16
DOWNGRADE
CANT
Sell
bluebird bio downgraded to Sell from Hold at Cantor
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell and cut his price target for the shares to $37 from $42.
10/14/16
CANT
10/14/16
DOWNGRADE
Target $37
CANT
Sell
Cantor cuts bluebird bio to Sell with $37 price target
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell from Hold and dropped his price target for the shares to $37 from $42. The biotech focused on developing gene therapies closed yesterday down 31c to $64.24. The analyst sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. Bluebird disclosed yesterday that all future LentiGlobin trials going forward will use its improved manufacturing process, and those trials are just beginning, Piros tells investors in a research note. As such, initial data on improved transduction efficiency may not become available until 2018, the analyst contends. With this year's ASH meeting not a catalyst, Piros expects selling pressure on bluebird shares.
10/14/16
LEER
10/14/16
NO CHANGE
Target $80
LEER
Outperform
bluebird bio price target raised to $80 from $67 at Leerink
Leerink analyst Michael Schmidt raised his price target for bluebird bio to $80 from $67 as he sees the clinical development and regulatory path for the company's pipeline products incrementally more de-risked. While development of key product LentiGlobin in transfusion-dependent beta-thalassemia and severe sickle cell disease has been more complex than initially anticipated, the analyst believes bluebird bio is well positioned to overcome remaining technical hurdles. He reiterates an Outperform rating on the shares.
10/14/16
RHCO
10/14/16
NO CHANGE
RHCO
bluebird bio outlook has improved, says SunTrust
SunTrust analyst Edward Nash believes that the improvement in the transduction efficiency of bluebird's LentiGlobin should enable the company "to target the entire transfusion-dependent B-thalassemia population" for the first time. Nash adds that the changes should also improve LentiGlobin's efficacy in sickle cell. He reiterates a $115 price target and Buy rating on the stock.
FLR Fluor
$49.97

-0.35 (-0.70%)

07/05/16
FBCO
07/05/16
NO CHANGE
FBCO
Outperform
Fluor scope on 'imminent' project could be multiple billions, says Credit Suisse
Credit Suisse Jamie Cook noted that the Tengizchevron joint venture, which is 50% owned by Chevron (CVX), 25% by ExxonMobil (XOM), 20% owned by KazMunayGas, and 5% owned by Lukoil, has announced plans to move forward with the TCO project, adding that Fluor (FLR) has been doing extensive work on TCO with its JV partner WorleyParsons and that most investors believed the likelihood of this project moving forward was "minimal." Cook, who believes Fluor's scope on this project could be "north of a couple billion" and that the company could book this award in Q2 or Q3 of this year, has an Outperform rating on Fluor shares.
06/28/16
MKMP
06/28/16
INITIATION
MKMP
Neutral
Fluor initiated with a Neutral at MKM Partners
05/06/16
ADAM
05/06/16
DOWNGRADE
ADAM
Hold
Fluor downgraded to Hold from Buy at Canaccord
10/14/16
GHSC
10/14/16
DOWNGRADE
Target $50
GHSC
Neutral
Fluor downgraded to Neutral from Accumulate at Seaport Global
Seaport Global analyst Ryan Cassil downgraded Fluor to Neutral and lowered its price target to $50 from $53 to account for persistently weaker global macroeconomic trends and expectations for a continuation of weaker project activity in 2017.
SAM Boston Beer
$154.88

-8.3 (-5.09%)

10/14/16
BREN
10/14/16
DOWNGRADE
BREN
Hold
Boston Beer downgraded to Hold from Buy at Berenberg
09/21/16
09/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Starbucks (SBUX) initiated with a Buy at Longbow. 2. Boston Beer (SAM) initiated with an Outperform at William Blair. 3. Altria Group (MO) was initiated with a Hold at Jefferies while the firm initiated Reynolds American (RAI) with a Buy. 4. Dick's Sporting (DKS) initiated with a Neutral at Guggenheim. 5. E-Trade (ETFC) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
09/21/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Neutral from Overweight at JPMorgan with analyst Vivek Juneja saying the "tough" Senate hearings and "mounting public scrutiny" will likely result in additional investigations that could pressure expenses. 2. Skechers (SKX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Jay Sole saying he believes consumers shift towards pure fashion styles and away from athletic footwear is causing Skechers to adjust assortment, resulting in slower sales growth. 3. American Airlines (AAL) downgraded to Market Perform from Outperform at Raymond James analyst Savanthi Syth citing relative valuation and lowered estimates to reflect the new mechanics contract. 4. Boston Beer (SAM) downgraded to Underperform from Market Perform at Cowen with analyst Vivien Azer citing its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. 5. Children's Place (PLCE) downgraded to Neutral from Overweight at Piper Jaffray with analyst Stephanie Wissink saying the firm's recent survey of moms pointed to a "step down" in mindshare. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/21/16
COWN
09/21/16
DOWNGRADE
Target $128
COWN
Underperform
Boston Beer downgraded to Underperform at Cowen
As reported previously, Cowen analyst Vivien Azer downgraded Boston Beer to Underperform from Market Perform. The analyst cited its string of disappointing monthly Nielsen data and structural headwinds to the company's core assets, which present meaningful earnings risk. Azer lowered her price target to $128 from $170 on Boston Beer shares, which were also initiated with an Outperform rating by William Blair analyst Jon Andersen this morning.
EL Estee Lauder
$87.80

-0.35 (-0.40%)

10/13/16
PIPR
10/13/16
UPGRADE
Target $44
PIPR
Overweight
Under Armour upgraded to Overweight after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Erinn Murphy upgraded Under Armour (UA) to Overweight from Neutral following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The survey findings support on-going traction for Under Armour within footwear and the women's segment, noted Murphy, who raised her price target on the stock to $44 from $40. Based on the survey's results, other analysts at the firm also downgraded Estee Lauder (EL) to Neutral from Overweight and upgraded Zumiez (ZUMZ) to Overweight from Neutral.
10/13/16
PIPR
10/13/16
DOWNGRADE
PIPR
Neutral
Estee Lauder downgraded to Neutral after teen survey at Piper Jaffray
As previously reported, Piper Jaffray analyst Steph Wissink downgraded Estee Lauder to Neutral from Overweight following the firm's semi-annual proprietary "Taking Stock With Teens" survey. The company's brands have ceded share both year-over-year and sequentially since spring, noted Wissink, who added that she believes its legacy brands are less able to rely on traditional marketing and promotion to gain share. The analyst cut her price target on Estee Lauder to $90 from $98.
10/13/16
PIPR
10/13/16
DOWNGRADE
PIPR
Neutral
Estee Lauder downgraded to Neutral from Overweight at Piper Jaffray
10/03/16
PIPR
10/03/16
NO CHANGE
PIPR
Chinese tax changes modestly positive for cosmetics makers, says Piper Jaffray
Piper Jaffray analyst Stephanie Wissink noted that the Chinese Ministry of Finance has reduced or eliminated the consumption tax on all cosmetic products as of October 1 to stimulate demand and growth, which she views as a modest positive for Estee Lauder (EL), Avon Products (AVP) and Coty (COTY). Of the three, Estee Lauder has the highest exposure to China, which makes up about 10% of its annual revenues, Wissink added.

TODAY'S FREE FLY STORIES

UTX

United Technologies

$112.09

-0.57 (-0.51%)

18:32
02/23/17
02/23
18:32
02/23/17
18:32
Hot Stocks
Carrier expands air conditioner, heat pump recall »

United Technologies'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

, BUD

AB InBev

$108.76

-0.4 (-0.37%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Craft Brew reschedules Q4 report to allow additional time for audit »

Craft Brew Alliance…

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

BUD

AB InBev

$108.76

-0.4 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GLPG

Galapagos NV

$69.96

0.3 (0.43%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Galapagos doses first healthy volunteer with CF combo GLPG2222, GLPG2451 »

Galapagos announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

RH

Restoration Hardware

$25.19

-0.82 (-3.15%)

, SENS

Senseonics

18:15
02/23/17
02/23
18:15
02/23/17
18:15
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: RH…

RH

Restoration Hardware

$25.19

-0.82 (-3.15%)

SENS

Senseonics

OLED

Universal Display

$67.45

-3.8 (-5.33%)

JWN

Nordstrom

$43.94

-1.41 (-3.11%)

EBS

Emergent BioSolutions

$29.78

-0.14 (-0.47%)

STMP

Stamps.com

$133.75

-0.7 (-0.52%)

MELI

MercadoLibre

$199.82

-0.59 (-0.29%)

BIDU

Baidu

$184.64

-1.37 (-0.74%)

HLF

Herbalife

$59.40

-1.34 (-2.21%)

GPS

Gap

$23.97

-0.9 (-3.62%)

AXDX

Accelerate Diagnostics

$24.75

0.3 (1.23%)

INCY

Incyte

$121.95

0.59 (0.49%)

DDS

Dillard's

$54.68

-0.56 (-1.01%)

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

CXW

CoreCivic

$34.00

-0.5 (-1.45%)

GEO

Geo Group

$47.37

-0.38 (-0.80%)

SRPT

Sarepta

$30.15

-0.23 (-0.76%)

ACIA

Acacia Communications

$63.43

1.21 (1.94%)

ZOES

Zoe's Kitchen

$22.46

-0.34 (-1.49%)

ACHC

Acadia

$43.24

0.6 (1.41%)

BGS

B&G Foods

$46.90

-0.65 (-1.37%)

SPLK

Splunk

$64.90

-0.08 (-0.12%)

HPE

HP Enterprise

$24.66

-0.12 (-0.48%)

ACHN

Achillion

$4.24

0.04 (0.95%)

PFGC

Performance Food Group

$24.35

0.4 (1.67%)

NAO

Nordic American Offshore

$2.05

-0.05 (-2.38%)

CELG

Celgene

$119.46

0.19 (0.16%)

HCLP

Hi-Crush Partners

$20.55

-1.4 (-6.38%)

SWN

Southwestern Energy

$8.35

-0.22 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 03

    Mar

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    Apr

  • 05

    Apr

  • 19

    Apr

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

COF

Capital One

$93.41

0.52 (0.56%)

18:11
02/23/17
02/23
18:11
02/23/17
18:11
Hot Stocks
Capital One: DOJ, Treasury, New York probing anti-money laundering program »

Capital One disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

XOM

Exxon Mobil

$81.78

0.85 (1.05%)

18:07
02/23/17
02/23
18:07
02/23/17
18:07
Hot Stocks
New Exxon Mobil CEO: 'Climate risks warrant action' »

New Exxon Mobil CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNT

Alliant Energy

$39.11

0.46 (1.19%)

18:04
02/23/17
02/23
18:04
02/23/17
18:04
Earnings
Alliant Energy sees FY17 EPS $1.92-$2.06, consensus $2.00 

Sees FY17 CapEx $1.4B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

LNT

Alliant Energy

$39.11

0.46 (1.19%)

18:02
02/23/17
02/23
18:02
02/23/17
18:02
Earnings
Alliant Energy reports Q4 EPS 28c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

STZ

Constellation Brands

$153.60

-6.6 (-4.12%)

17:57
02/23/17
02/23
17:57
02/23/17
17:57
Hot Stocks
Constellation Brands says 'ready to act' in any border tax situation »

Sees over $1B in free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

, CLC

Clarcor

$82.96

-0.02 (-0.02%)

17:53
02/23/17
02/23
17:53
02/23/17
17:53
Hot Stocks
CyrusOne to replace Clarcor in S&P 400 as of 3/1 open »

S&P 500 constituent…

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

CLC

Clarcor

$82.96

-0.02 (-0.02%)

PH

Parker-Hannifin

$153.70

-2.16 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 06

    Mar

DDS

Dillard's

$54.68

-0.56 (-1.01%)

, ISIL

Intersil

17:52
02/23/17
02/23
17:52
02/23/17
17:52
Hot Stocks
Dillard's to replace Intersil in S&P 400 as of 2/28 open »

Renesas Electronics Corp.…

DDS

Dillard's

$54.68

-0.56 (-1.01%)

ISIL

Intersil

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

, EQY

Equity One

$31.91

0.39 (1.24%)

17:50
02/23/17
02/23
17:50
02/23/17
17:50
Hot Stocks
Breaking Hot Stocks news story on Nu Skin, Equity One »

Nu Skin to replace Equity…

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ENDP

Endo

$13.39

0.5 (3.88%)

, REG

Regency Centers

$70.95

0.94 (1.34%)

17:49
02/23/17
02/23
17:49
02/23/17
17:49
Hot Stocks
Breaking Hot Stocks news story on Endo, Regency Centers »

Endo to replace Regency…

ENDP

Endo

$13.39

0.5 (3.88%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Mar

REG

Regency Centers

$70.95

0.94 (1.34%)

, ENDP

Endo

$13.39

0.5 (3.88%)

17:48
02/23/17
02/23
17:48
02/23/17
17:48
Hot Stocks
Regency Centers to replace Endo in S&P 500 as of 3/2 open »

Regency Centers (REG) is…

REG

Regency Centers

$70.95

0.94 (1.34%)

ENDP

Endo

$13.39

0.5 (3.88%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Mar

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

, CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

17:46
02/23/17
02/23
17:46
02/23/17
17:46
Hot Stocks
Breaking Hot Stocks news story on Pitney Bowes, CBOE Holdings »

Pitney Bowes to replace…

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

, PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

17:45
02/23/17
02/23
17:45
02/23/17
17:45
Hot Stocks
CBOE Holdings to repplace Pitney Bowes in S&P 500 as of 3/1 open »

CBOE (CBOE) is acquiring…

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

BATS

Bats Global Markets

$35.65

-0.08 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

INCY

Incyte

$121.95

0.59 (0.49%)

, SE

Spectra Energy

$41.00

-0.31 (-0.75%)

17:42
02/23/17
02/23
17:42
02/23/17
17:42
Hot Stocks
Incyte to replace Spectra Energy in S&P 500 as of 2/28 open »

Spectra Energy (SE) is…

INCY

Incyte

$121.95

0.59 (0.49%)

SE

Spectra Energy

$41.00

-0.31 (-0.75%)

ENB

Enbridge

$41.71

-0.44 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 01

    Apr

  • 19

    Apr

STMP

Stamps.com

$133.75

-0.7 (-0.52%)

17:41
02/23/17
02/23
17:41
02/23/17
17:41
Earnings
Stamps.com reports Q4 EPS $2.73, consensus $2.36 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$121.95

0.59 (0.49%)

, CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

17:39
02/23/17
02/23
17:39
02/23/17
17:39
Hot Stocks
Breaking Hot Stocks news story on Incyte, CBOE Holdings, Regency Centers »

Incyte, CBOE Holdings,…

INCY

Incyte

$121.95

0.59 (0.49%)

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 06

    Mar

  • 14

    Mar

  • 01

    Apr

  • 19

    Apr

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:36
02/23/17
02/23
17:36
02/23/17
17:36
Earnings
MasTec sees Q1 adjusted EPS 51c, consensus 23c »

Sees Q1 revenue $1.05B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:36
02/23/17
02/23
17:36
02/23/17
17:36
Earnings
MasTec sees FY17 adjusted EPS $2.35, consensus $2.09 »

Sees FY17 revenue $5.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

GOOG

Alphabet

$831.33

0.57 (0.07%)

, GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

17:35
02/23/17
02/23
17:35
02/23/17
17:35
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

Alphabet's Waymo…

GOOG

Alphabet

$831.33

0.57 (0.07%)

GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

  • 19

    Mar

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
MasTec reports Q4 adjusted EPS 70c, consensus 54c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SSRI

Silver Standard

$10.90

-0.06 (-0.55%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
Silver Standard reports Q4 adjusted EPS 26c, consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ALJ

Alon USA Energy

$11.73

0.17 (1.47%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
Alon USA Energy reports Q4 EPS ex-items (20c), consensus (33c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.